The unadjusted and adjusted analyses of the primary composite outcome of TVF and its components at 3 years in patients with non–insulin-treated DM (n = 6,930) and those with insulin-treated DM (n = 893) are shown in Supplemental Tables 4 and 5, respectively. The gene discussed is INS; the disease is diabetes mellitus.